Sean Wieland
Stock Analyst at Piper Sandler
(1.86)
# 3,241
Out of 5,154 analysts
31
Total ratings
45.45%
Success rate
2.25%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Overweight | $57 → $55 | $41.30 | +33.17% | 12 | Aug 11, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $35 → $36 | $23.27 | +54.71% | 3 | Aug 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $5.46 | +2,097.80% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $15.74 | -61.88% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $25.34 | +73.64% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $174.49 | +32.39% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $5.08 | +5,628.35% | 5 | Feb 25, 2021 |
Omnicell
Aug 11, 2025
Maintains: Overweight
Price Target: $57 → $55
Current: $41.30
Upside: +33.17%
Privia Health Group
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $36
Current: $23.27
Upside: +54.71%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $5.46
Upside: +2,097.80%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $15.74
Upside: -61.88%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $25.34
Upside: +73.64%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $174.49
Upside: +32.39%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $5.08
Upside: +5,628.35%